BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6147434)

  • 1. Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia.
    Takasaki Y; Robinson WA; Tan EM
    J Natl Cancer Inst; 1984 Sep; 73(3):655-61. PubMed ID: 6147434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of B-cell antigen on the blast cells in chronic myeloid leukemia].
    Morozova LF; Belianchikova NI; Radzikhovskaia RM; Baryshnikov AIu; Volkova MA
    Biull Eksp Biol Med; 1979 Jun; 87(6):574-6. PubMed ID: 380683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of an antigen, associated with cells during the blast crisis of chronic myeloleukemia, in a cytotoxic test using xenogenic antibodies].
    Baryshnikov AIu; Radzikhovskaia RM; Morozova LF; Slavina EG; Belianchikova NI
    Biull Eksp Biol Med; 1977 Jun; 83(6):719-21. PubMed ID: 267492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-PCNA antibody].
    Yamanaka K; Takasaki Y
    Rinsho Byori; 1993 Aug; 41(8):888-96. PubMed ID: 8103808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of antibody in acute myeloid leukaemia with proliferation-associated nuclear antigen(s).
    Russell AR; Pope JH
    Clin Exp Immunol; 1976 Jan; 23(1):83-90. PubMed ID: 1063068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of both T-cell and Ia-like antigens on cells from patients with acute myelomonocytic leukemia and chronic myelogenous leukemia in blast crisis.
    Anderson JK; Moore JO; Metzgar RS
    Cancer Res; 1979 Dec; 39(12):4810-5. PubMed ID: 91428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloblastic and lymphoblastic markers in acute undifferentiated leukemia and chronic myelogenous leukemia in blast crisis.
    Shumak KH; Baker MA; Taub RN; Coleman MS
    Cancer Res; 1980 Nov; 40(11):4048-52. PubMed ID: 6937237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific xenogenous antiserum to cells of chronic myeloid leukemia (CML) in blastic crisis.
    Baryshnikov AJ; Radzikhovskaya RM; Morozova LF; Belyanchikova NI; Slavina EG; Vinogradova JE; Mkheidze DM; Polotskaya TM; Volkova MA; Svet-Moldavsky GJ; Nikitin VD; Kutimov VA; Trubitsina VI; Goletsky SA; Glazunov A
    Biomedicine; 1976 Dec; 25(9):316-7. PubMed ID: 1069594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel diagnostic and clinical aspects of anti-PCNA antibodies detected by novel detection methods.
    Mahler M; Silverman ED; Fritzler MJ
    Lupus; 2010 Nov; 19(13):1527-33. PubMed ID: 20647252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of heteroantisera to human acute leukemia-associated antigens.
    Baker MA; Ramachandar K; Taub RN
    J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity of monoclonal anti-K 562 antibodies with cells of leukemia- and lymphoma-patients.
    Hering S; Böttger V; Baryschnikow AJ; Micheel B
    Arch Geschwulstforsch; 1985; 55(1):9-16. PubMed ID: 3885896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies.
    Inoue T; Yamane T; Park K; Im T; Tatsumi N; Okuda K
    Arch Pathol Lab Med; 1993 Oct; 117(10):969-72. PubMed ID: 8105766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoclonal antibodies ICO-02 to blast cell antigens in patients with chronic myeloleukemia in blast crisis].
    Baryshnikov AIu
    Eksp Onkol; 1984; 6(5):53-5. PubMed ID: 6239771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A monoclonal antibody identifies a 215 000-dalton nuclear envelope protein restricted to certain cell types.
    Brown G; Turner BM; Morris CJ; Bahman AM; Fisher AG; Whitfield WG; Davies S; Barthakur R; Johnson GD
    Eur J Cell Biol; 1985 Nov; 39(1):86-96. PubMed ID: 2417847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-cycle-associated expressions of proliferating cell nuclear antigen and Ki-67 reactive antigen of bone marrow blast cells in childhood acute leukemia.
    Tsurusawa M; Ito M; Zha Z; Kawai S; Takasaki Y; Fujimoto T
    Leukemia; 1992 Jul; 6(7):669-74. PubMed ID: 1352561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of carbohydrate structures in individual maturation stages of myeloid leukemic cells.
    Noworolska A; Slesak B; Harłonzińska A; Richter R
    Neoplasma; 1991; 38(1):57-62. PubMed ID: 2011210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of proliferation and quiescence associated antigens in acute myeloid leukemia correlates with survival duration: analysis of 15 refractory cases.
    Visani G; Ottaviani E; Danova M; Mangiarotti R; Tosi P; Tura S
    Haematologica; 1997; 82(3):338-40. PubMed ID: 9234585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune response to proteins of proliferating cell nuclear antigen multiprotein complexes in patients with connective tissue diseases.
    Kaneda K; Takasaki Y; Takeuchi K; Yamada H; Nawata M; Matsushita M; Matsudaira R; Ikeda K; Yamanaka K; Hashimoto H
    J Rheumatol; 2004 Nov; 31(11):2142-50. PubMed ID: 15517625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of surface nonspecific cross-reacting antigen and influence of proteolytic enzymes on this antigen in myeloid cell series.
    Noworolska A; Harłozińska-Szmyrka A; Richter R
    Cancer Detect Prev; 1986; 9(3-4):365-71. PubMed ID: 3527416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.